209 filings
Page 8 of 11
8-K
n5jb tbjy
20 Apr 15
ChromaDex Appoints Former GlaxoSmithKline Executive, Jeff Baxter, to Its Board of Directors
12:00am
8-K
xhu jzgua3wg
20 Mar 15
Departure of Directors or Certain Officers
12:00am
8-K
musb6n1a
3 Mar 15
ChromaDex® Appoints Former Nestlé Executive, Steve Allen, as Chairman
12:00am
8-K
iuohb pp16a
11 Feb 15
Regulation FD Disclosure
12:00am
8-K
0kav77
12 Jan 15
Regulation FD Disclosure
12:00am
8-K
hzg0a79sqv6
3 Dec 14
ChromaDex® Receives $750,000 Cash from Previous Sale of its BluScience™ Line
12:00am
8-K
q7bnszo
2 Dec 14
ChromaDex Licenses Exclusive Worldwide Patent Rights from the University of Mississippi for Microalgae Technology Targeting Immune Support
12:00am
8-K
dud zzsar7
3 Oct 14
Entry into a Material Definitive Agreement
12:00am
8-K
ft10mk0xji rh1ekvt
30 Sep 14
ChromaDex Secures $5.0 Million in Growth Capital Financing from Hercules
12:00am
8-K
xjersnd d1drhf
22 Sep 14
Entry into a Material Definitive Agreement
12:00am
8-K
zif4bg
12 Aug 14
Regulation FD Disclosure
12:00am
8-K
cnr17jhz
3 Jun 14
Entry into a Material Definitive Agreement
12:00am
8-K
qsbneoii40r 01x
10 Mar 14
Entry into a Material Definitive Agreement
12:00am
8-K
9l2kyecu8 bi6
6 Jan 14
Entry into a Material Definitive Agreement
12:00am
8-K
gha7ra
6 Jan 14
Departure of Directors or Certain Officers
12:00am
8-K
xnf40dtb
3 Jan 14
Entry into a Material Definitive Agreement
12:00am
8-K
793uf
30 Dec 13
Changes in Registrant's Certifying Accountant
12:00am
8-K
hqj0vmec no3qq
17 Dec 13
Changes in Registrant's Certifying Accountant
12:00am
8-K
hntiwq
4 Dec 13
Regulation FD Disclosure
12:00am
8-K
u7p5q3r9x3meynn9fq
21 Nov 13
Results of Operations and Financial Condition
12:00am